https://www.isx.financial/blog/isxuspatents?utm_content=193076872&utm_medium=social&utm_source=twitter&hss_channel=tw-1351472038498738176
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%